Joseph L. Goldstein - 10 Sep 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Joseph L. Goldstein
Issuer symbol
REGN
Transactions as of
10 Sep 2021
Net transactions value
-$666,975
Form type
4
Filing time
13 Sep 2021, 16:01:44 UTC
Previous filing
08 Jun 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $944,375 +2,479 +42% $380.95 8,370 10 Sep 2021 Direct F1
transaction REGN Common Stock Sale $1,611,350 -2,479 -30% $650.00 5,891 10 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,479 -100% $0.000000* 0 10 Sep 2021 Common Stock 2,479 $380.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.